Profound Medical Corp. (TSE:PRN - Get Free Report)'s stock price rose 0.3% during trading on Monday . The company traded as high as C$10.92 and last traded at C$10.76. Approximately 5,830 shares changed hands during trading, a decline of 18% from the average daily volume of 7,076 shares. The stock had previously closed at C$10.73.
Profound Medical Trading Down 0.2 %
The company has a current ratio of 8.61, a quick ratio of 14.98 and a debt-to-equity ratio of 16.95. The company has a market cap of C$262.92 million, a price-to-earnings ratio of -6.51 and a beta of 0.83. The firm has a 50-day moving average price of C$12.40 and a 200 day moving average price of C$11.64.
Profound Medical (TSE:PRN - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported C($0.38) earnings per share for the quarter, meeting the consensus estimate of C($0.38). The business had revenue of C$3.06 million for the quarter, compared to the consensus estimate of C$3.42 million. As a group, sell-side analysts forecast that Profound Medical Corp. will post -1.9000001 EPS for the current year.
Insider Buying and Selling
In other news, Senior Officer Rashed Osman Dewan purchased 9,765 shares of Profound Medical stock in a transaction dated Thursday, August 15th. The stock was bought at an average price of C$12.85 per share, with a total value of C$125,480.25. Company insiders own 8.66% of the company's stock.
Profound Medical Company Profile
(
Get Free Report)
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
Read More
Before you consider Profound Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Profound Medical wasn't on the list.
While Profound Medical currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
